SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-014489
Filing Date
2017-07-31
Accepted
2017-07-31 16:06:20
Documents
61
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbph-10q_20170630.htm 10-Q 1471362
2 EX-31.1 sbph-ex311_6.htm EX-31.1 18461
3 EX-31.2 sbph-ex312_7.htm EX-31.2 18174
4 EX-32.1 sbph-ex321_8.htm EX-32.1 16328
  Complete submission text file 0001564590-17-014489.txt   6532921

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sbph-20170630.xml EX-101.INS 1621339
6 XBRL TAXONOMY EXTENSION SCHEMA sbph-20170630.xsd EX-101.SCH 42068
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sbph-20170630_cal.xml EX-101.CAL 43972
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sbph-20170630_def.xml EX-101.DEF 149679
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sbph-20170630_lab.xml EX-101.LAB 354923
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sbph-20170630_pre.xml EX-101.PRE 277729
Mailing Address 86 SOUTH STREET HOPKINTON MA 01748
Business Address 86 SOUTH STREET HOPKINTON MA 01748 508-473-5993 X119
Spring Bank Pharmaceuticals, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 17993031
SIC: 2834 Pharmaceutical Preparations